Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%) Natco Pharma - Quaterly Results
Date: 14-11-2023
The total revenue surged to Rs. 9305.00 millions, up 165.02% for the September 2023 quarter as against Rs. 3511.00 millions during the year-ago period.The Total revenue for the quarter ended September 2023 of Rs. 3602.00 millions grew by 855.44% from Rs. 377.00 millions.Operating profit surged to 4670.00 millions from the corresponding previous quarter of 863.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 9305.00 | 3511.00 | 165.02 | 19788.00 | 11568.00 | 71.06 | 23510.00 | 17678.00 | 32.99 |
| Other Income | 247.00 | 162.00 | 52.47 | 393.00 | 494.00 | -20.45 | 855.00 | 946.00 | -9.62 |
| PBIDT | 4670.00 | 863.00 | 441.14 | 9853.00 | 4989.00 | 97.49 | 9302.00 | 3076.00 | 202.41 |
| Interest | 30.00 | 17.00 | 76.47 | 62.00 | 44.00 | 40.91 | 86.00 | 133.00 | -35.34 |
| PBDT | 4640.00 | 846.00 | 448.46 | 9791.00 | 4945.00 | 98.00 | 9216.00 | 2943.00 | 213.15 |
| Depreciation | 400.00 | 383.00 | 4.44 | 799.00 | 752.00 | 6.25 | 1509.00 | 1384.00 | 9.03 |
| PBT | 4240.00 | 463.00 | 815.77 | 8992.00 | 4193.00 | 114.45 | 7707.00 | 1559.00 | 394.36 |
| TAX | 638.00 | 86.00 | 641.86 | 1337.00 | 736.00 | 81.66 | 1336.00 | 168.00 | 695.24 |
| Deferred Tax | -115.00 | -6.00 | 1816.67 | -254.00 | -16.00 | 1487.50 | 5.00 | -157.00 | -103.18 |
| PAT | 3602.00 | 377.00 | 855.44 | 7655.00 | 3457.00 | 121.43 | 6371.00 | 1391.00 | 358.02 |
| Equity | 358.00 | 365.00 | -1.92 | 358.00 | 365.00 | -1.92 | 365.00 | 365.00 | 0.00 |
| PBIDTM(%) | 50.19 | 24.58 | 104.18 | 49.79 | 43.13 | 15.45 | 39.57 | 17.40 | 127.39 |